SE8705197D0 - New peptides, two diagnostic methods using the peptides and a medicament based on the peptides - Google Patents

New peptides, two diagnostic methods using the peptides and a medicament based on the peptides

Info

Publication number
SE8705197D0
SE8705197D0 SE8705197A SE8705197A SE8705197D0 SE 8705197 D0 SE8705197 D0 SE 8705197D0 SE 8705197 A SE8705197 A SE 8705197A SE 8705197 A SE8705197 A SE 8705197A SE 8705197 D0 SE8705197 D0 SE 8705197D0
Authority
SE
Sweden
Prior art keywords
peptides
hiv
ala
gln
leu
Prior art date
Application number
SE8705197A
Other languages
English (en)
Inventor
Jonas Blomberg
Rudiger Pipkorn
Per Johan Klasse
Original Assignee
Jonas Blomberg
Rudiger Pipkorn
Per Johan Klasse
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jonas Blomberg, Rudiger Pipkorn, Per Johan Klasse filed Critical Jonas Blomberg
Priority to SE8705197A priority Critical patent/SE8705197D0/sv
Publication of SE8705197D0 publication Critical patent/SE8705197D0/sv
Priority to AU29131/89A priority patent/AU621855B2/en
Priority to EP88850434A priority patent/EP0323424A3/en
Priority to PCT/SE1988/000699 priority patent/WO1989006240A1/en
Priority to AU29131/89A priority patent/AU2913189A/en
Priority to JP1501067A priority patent/JPH04503204A/ja
Priority to DK156490A priority patent/DK156490A/da
Priority to NO90902926A priority patent/NO902926L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8705197A 1987-12-30 1987-12-30 New peptides, two diagnostic methods using the peptides and a medicament based on the peptides SE8705197D0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE8705197A SE8705197D0 (sv) 1987-12-30 1987-12-30 New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
AU29131/89A AU621855B2 (en) 1987-12-30 1988-12-23 Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides
EP88850434A EP0323424A3 (en) 1987-12-30 1988-12-23 Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides
PCT/SE1988/000699 WO1989006240A1 (en) 1987-12-30 1988-12-23 Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides
AU29131/89A AU2913189A (en) 1987-12-30 1988-12-23 Peptide corresponding to hiv-env 583-599, and analogs thereof and applications of the peptides
JP1501067A JPH04503204A (ja) 1987-12-30 1988-12-23 ＨＩＶ―ｅｎｖ　５８３―５９９に対応するペプチドとその類似体、およびそれらのペプチドの応用
DK156490A DK156490A (da) 1987-12-30 1990-06-28 Peptid svarende til hiv-env 583-599 og analoge dertil samt anvendelse af peptiderne
NO90902926A NO902926L (no) 1987-12-30 1990-06-29 Peptid tilsvarende hiv-env 583-599, og analoger derav, samt anvendelser av peptidene.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8705197A SE8705197D0 (sv) 1987-12-30 1987-12-30 New peptides, two diagnostic methods using the peptides and a medicament based on the peptides

Publications (1)

Publication Number Publication Date
SE8705197D0 true SE8705197D0 (sv) 1987-12-30

Family

ID=20370739

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8705197A SE8705197D0 (sv) 1987-12-30 1987-12-30 New peptides, two diagnostic methods using the peptides and a medicament based on the peptides

Country Status (7)

Country Link
EP (1) EP0323424A3 (sv)
JP (1) JPH04503204A (sv)
AU (2) AU2913189A (sv)
DK (1) DK156490A (sv)
NO (1) NO902926L (sv)
SE (1) SE8705197D0 (sv)
WO (1) WO1989006240A1 (sv)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6887096A (en) * 1996-09-11 1998-04-02 Patrick T. Prendergast Immune direction therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588254T2 (de) * 1984-10-18 2008-06-26 Institut Pasteur GAG-Antigen und dessen Verwendung zum Nachweis von LAV-Infektion, sowie in immunogenen Zusammensetzungen
WO1986006414A1 (en) * 1985-04-29 1986-11-06 Genetic Systems Corporation Synthetic antigens for the detection of aids-related disease
JP2702911B2 (ja) * 1985-09-11 1998-01-26 ユナイテツド・バイオメデイカル・インコ−ポレ−テツド 合成ペプチド、並びにそれを用いたエイズおよびプリ・エイズの検出方法
DE3788397T3 (de) * 1986-03-24 2003-11-27 Ortho Pharmaceutical Corp., Raritan Synthetische htlv-iii-peptid-zusammensetzungen und ihre verwendung.
US4879212A (en) * 1986-04-02 1989-11-07 United Biomedical Inc. Peptide composition and method for the detection of antibodies to HTLV-III
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
EP0247557B1 (en) * 1986-05-27 1994-04-20 F. Hoffmann-La Roche Ag HTLV-III(LAV) Envelope peptides
EP0300031A4 (en) * 1987-01-28 1990-05-14 Ortho Pharma Corp IMMUNE SUPPRESSIVE PEPTIDES AND METHOD FOR THEIR USE.

Also Published As

Publication number Publication date
DK156490D0 (da) 1990-06-28
AU621855B2 (en) 1992-03-26
JPH04503204A (ja) 1992-06-11
AU2913189A (en) 1989-08-01
NO902926D0 (no) 1990-06-29
EP0323424A3 (en) 1990-08-16
DK156490A (da) 1990-08-22
WO1989006240A1 (en) 1989-07-13
EP0323424A2 (en) 1989-07-05
NO902926L (no) 1990-08-30

Similar Documents

Publication Publication Date Title
DE69018113T2 (de) Hemmer der Proteasen von Retroviren.
DE68928130D1 (de) Synthetische vom HIV-GP120-env-Protein abgeleitete Peptide und ihre Anwendung
US5756449A (en) Peptide T and related peptides in the treatment of inflammation, including inflammatory bowel disease
US5276016A (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
EP1196450B1 (fr) Derives citrullines de la fibrine et leur utilisation pour le diagnostic ou le traitement de la polyarthrite rhumato de
GB2190679B (en) Hiv virus gag and thymosin related peptides and associated antibodies,vaccines,immunisation against aids virus and tests for detecting the aids virus.
US5346989A (en) Peptides for use in induction of T cell activation against HIV-1
JPH06247874A (ja) ほにゅう動物の熱帯けいれん性不全マヒおよびｈｔｌｖ−１伝染患者の神経衝動および認識性挙動の治療方法
US6011014A (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
EP0960886B1 (en) Peptide T and related peptides in the treatment of inflammation, including multiple sclerosis
SE8705197D0 (sv) New peptides, two diagnostic methods using the peptides and a medicament based on the peptides
AU662534B2 (en) Peptides for use in induction of T cell activation against HIV-1
DE69433057T2 (de) Peptide zur verwendung bei der impfung und induktion neutralisierender antikörper gegen das menschliche immunschwäche-virus
DK0426314T3 (da) HIV-relaterede peptider
FR2694938B1 (fr) Nouveaux peptides, anticorps diriges contre ces peptides, anticorps anti-idiotypiques, application a titre de medicaments, compositions pharmaceutiques et kits de diagnostic les renfermant.
JP3115596B2 (ja) ヒト免疫不全ウィルス感染を阻止するペプチドとその使用法
Chen et al. A common immunological epitope existing between HIV-1 gp41 and human interferon-α and-β
IE61725B1 (en) Small peptides which inhibit binding to T-4 receptors and act as immunogens
Syennerholm et al. Vahlne et al.